These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
    Author: Levine AE, Crandall CA.
    Journal: Cancer Res; 1987 Aug 15; 47(16):4278-82. PubMed ID: 3496961.
    Abstract:
    Transforming growth factor-beta (TGF-beta) is a bifunctional reagent which can exert both stimulatory and inhibitory effects upon the same target cell. Treatment of growth arrested AKR-2B mouse embryo fibroblasts with TGF-beta has been shown to stimulate mitogenesis by an indirect mechanism. Addition of the differentiation agents N,N-dimethylformamide (DMF) or retinoic acid simultaneously with TGF-beta blocked the ability of TGF-beta to induce mitogenesis. These agents partially blocked the mitogenic effects of epidermal growth factor and platelet-derived growth factor. DMF blocked TGF-beta induced mitogenesis when added 9 h, but not 24 h, after TGF-beta addition suggesting that DMF affects an early step in the mitogenic cascade induced by TGF-beta. TGF-beta will induce anchorage independent growth in AKR-2B fibroblasts and this was also inhibited by DMF. When AKR-2B cells were grown in monolayer culture, TGF-beta inhibited their growth. The addition of DMF under these conditions did not alter the cell's sensitivity to TGF-beta and the cells were still inhibited to the same extent by TGF-beta. Therefore, DMF did not affect the inhibitory action of TGF-beta on AKR-2B fibroblasts but did block the stimulatory effects of TGF-beta.
    [Abstract] [Full Text] [Related] [New Search]